Jun 29, 2005 - 11:51 pm
If anyone here is or has been enrolled in a study using Sorafenib (BAY43-9006) in combination with Interferon alpha 2-b for metastatic renal cell carcinoma, I would love to ask you some questions about how you are doing with the trial. Things such as severity of side effects, etc. I know these vary by individual but at least it would be nice to chat with someone to see what I am facing.
P.S. You can reach me at email@example.com